Long-term ethanol treatment substantially impairs glycosylation and membrane trafficking in primary cultures of rat astrocytes. Our previous studies indicated that these effects were attributable to a primary alteration in the dynamics and organization of the actin cytoskeleton, although the molecular mechanism(s) remains to be elucidated. As small Rho GTPases and phosphoinositides are involved in the actin cytoskeleton organization, we now explore the effects of chronic ethanol treatment on these pathways. We show that chronic ethanol treatment of rat astrocytes specifically reduced endogenous levels of active RhoA as a result of the increase of in the RhoGAP activity. Furthermore, ethanol-treated astrocytes showed reduced phosphoinositides levels. When lysophosphatidic acid was added to ethanol-treated astrocytes, it rapidly reverted actin cytoskeleton reorganization and raised active RhoA levels and phosphoinositides content to those observed in untreated astrocytes. Overall, our results indicate that the harmful effects of chronic exposure to ethanol on a variety of actin dynamics-associated cellular events are primarily because of alterations of activated RhoA and phosphoinositides pools.
Chronic alcohol (ethanol) consumed during pregnancy causes a wide spectrum of physical and mental alterations in the offspring, which can lead to the appearance of the fetal alcohol syndrome. Fetal alcohol syndrome is characterized by pre-and/or post-natal growth deficiencies, microcencephaly, characteristic facial anomalies and mental retardation in neonates (Floyd et al. 2005; Krulewitch 2005; Martínez and Egea 2007 for recent reviews). The alteration of essential cellular processes has been proposed to explain the teratogenicity of ethanol (Martínez and Egea 2007) . One of them is that it perturbs the genesis, proliferation and survival of astrocytes (Guerri et al. 2001; Costa et al. 2004; Vemuri and Chetty 2005) . In this respect, we have previously reported that ethanol alters both actin cytoskeleton organization and microtubule dynamics in rat astrocytes (Tomás et al. 2003) , which suggests subsequent alterations of those cellular processes dependent on both cytoskeletons. Thus, we observed that in rat astrocytes ethanol impairs glucose uptake, and endocytic and secretory protein transport (Tomás et al. 2002 (Tomás et al. , 2003 , which in turn are associated with the state of actin cytoskeleton organization and dynamics (Lanzetti et al. 2001; Ridley 2006; Smythe and Ayscough 2006) .
Lysophosphatidic acid (LPA) is a serum component that stimulates Rho signalling pathway, which governs actin cytoskeleton organization and stabilizes microtubules (Cook et al. 1998; Jaffe and Hall 2005) . LPA mediates changes in cell shape by signalling through small G-proteins of the Rho family in several cell types (Ridley and Hall 1992; Jalink et al. 1994; Moolenaar et al. 2004) including astrocytes (Ramakers and Moolenaar 1998) . We have previously reported that LPA rescues the alterations in monosaccharide uptake and actin cytoskeleton organization caused by ethanol in rat astrocytes (Tomás et al. 2003) . The cytoprotective role of LPA could involve RhoA GTPase signalling, as the expression of a constitutively activated RhoA mutant (RhoA-V14) in both ethanol-treated astrocytes and NIH3T3 cells (Guasch et al. 2003; Tomás et al. 2003) renders cells resistant to ethanolinduced alterations in actin and monosaccharide uptake. Taking into account these results, we hypothesized a model to explain the respective effects of ethanol and LPA, in which we anticipated the involvement of the RhoA signalling pathway and phosphatidylinositol 4,5-bisphosphate (PIP 2 ) in the ethanol-induced actin cytoskeleton alterations (Tomás et al. 2003 ). Here we demonstrate that ethanol indeed decreases the endogenous levels of active (GTP-bound) RhoA pool (without altering Rac1 or Cdc42) and phosphoinositides levels, particularly PIP 2 . Strikingly, LPA treatment restores normal activated RhoA and phosphoinositides pools, thus providing a molecular mechanism for the cytoprotective role of LPA in front of ethanol exposure.
Material and methods

Plasmid construct and reagents
Dulbecco's modified Eagle's medium, Medium 199, fetal bovine serum (FBS), penicillin, streptomycin and glutamine were obtained from Gibco/Brl Life Technologies (Paisley, UK). LPA (oleoyl-L-alysophosphatidic acid sodium salt) and a-tubulin mouse monoclonal antibody were purchased from Sigma (St Louis, MO, USA). Rodamine-phalloidin was from Molecular Probes (Eugene, OR, USA). Culture reagents were all from Invitrogen (Paisley, UK). Mouse monoclonal antibodies against Cdc42, Rac1 or RhoA and secondary peroxidase-conjugated antibodies were from BD Transduction Laboratories (Lexington, KY, USA). Myo-[2- Primary cultures of rat astrocytes and ethanol treatment Primary cultures of cortical and cerebellum astrocytes were prepared from newborn (P1) Wistar rats as previously reported (Tomás et al. 2005) . Briefly, cells were plated into 75 cm 2 flasks in Dulbecco's modified Eagle's medium culture medium supplemented with 10% FBS. The cell cultures were incubated in a humidified atmosphere of 5% CO 2 at 37°C. The purity of astrocyte cultures was assessed by immunofluorescence using anti-glial fibrillary acidic protein monoclonal antibody (Renau-Piqueras et al. 1989) , which showed that cell cultures contained 90-95% of astrocytes. Before confluence, cells were replated and grown for at least 7 days in the absence or presence of ethanol, which was added to the culture medium when the cells were replated. Ethanol was added every 24 h to maintain constant ethanol concentration in the medium. For LPA treatments, cells were cultured for 12 h with low-serum medium (0.5% FBS) and subsequently with serum-free medium for 2 h before adding LPA (0.5-1 lmol/L). All experiments using rats were approved by the appropriate institutional review committee and performed in strict compliance with the European Community Guide for the Care and Use of Laboratory Animals.
Fluorescence microscopy Cultured astrocytes were fixed in 4% (w/w) formaldehyde in phosphate-buffered saline (PBS) for 30 min at 20°C, washed in PBS (3 · 5 min) and incubated in PBS containing 50 mmol/L ammonium chloride. Cells were then permeabilized for 10 min with PBS containing 0.1% saponin and 1% bovine serum albumin. Actin cytoskeleton was visualized by incubating cells for 30 min with 0.1 mg/mL of rodamine-labelled phalloidin. Stained cells were observed with a BX60 epifluorescence microscope (Olympus, Tokyo, Japan) with an Orca-ER cooled CCD camera (Hamamatsu Photonics, Japan). The images were processed using Adobe Photoshop CS software (Adobe Systems, San Jose, CA, USA).
Rho GTPases pull-down experiments and GTP-bound RhoA colorimetric assay GTP-bound Cdc42, Rac1 and RhoA were determined using co-precipitation assays as previously described (Ren et al. 1999) . GTP-Cdc42 and GTP-Rac1 interact with the PAK1 binding domain (PBD) fused to glutathione S-transferase (GST) bound to glutathionecoupled agarose beads. GTP-bound RhoA (but not GDP-bound Rho) specifically interacts with the Rhoketin binding domain (RBD), which is coupled to glutathione-coupled agarose beads. Briefly, astrocytes were scraped and lysed on ice in 450 lL lysis buffer, which for the GST-PBD pull-down experiments contained 20 mmol/L TrisHCl, pH 7.4, 150 mmol/L NaCl, 5 mmol/L MgCl 2 , 0.5% NP40, 5 mmol/L b-glycerophosphate, 1 mmol/L sodium orthovanadate, 10 lg/mL leupeptin, 10 lg/mL aprotinin; for the GST-RBD pulldown experiments the lysis buffer contained 50 mmol/L Tris-HCl, pH 7.4, 200 mmol/L NaCl, 2.5 mmol/L MgCl 2 , 1% NP40, 10% glycerol, 1 mmol/L sodium orthovanadate, 10 lg/mL leupeptin, 10 lg/mL aprotinin. Subsequently, lysates were microfuged at 10 000 g for 10 min at 4°C and the respective supernatants were transferred to a fresh, chilled microfuge tube containing 20 lg of either GST-PBD or GST-RBD sepharose beads. Affinity purifications were carried out at 4°C for 1 h, washed three times with 10 vol of lysis buffer, and then analysed by immunoblotting. Protein was measured in 25 lL of each supernatant by the Lowry method. Quantitative colorimetric assay utilizing and enzyme-linked immunosorbent assay (ELISA)-based RhoA activity detection method (G-LISA; Cytoskeleton Technology, Denver, CO, USA) was performed to measure RhoA activity in cell extracts following the manufacturer's instructions. Briefly, cell extracts were lysed by the buffer provided in the kit and lysates were incubated in microwells to which the RBD was bound. Active RhoA was detected using indirect immunodetection followed by a colorimetric reaction measured by absorbance at 490 nm.
RhoGAP/GEF activity assays
To determine RhoGAP activity, bacterially expressed RhoA was purified by standard procedures and loaded with c-[ 32 P]-GTP. For the GTPase-activating protein (GAP) reaction, GTP-loaded RhoA was incubated with lysates in the presence of MgCl 2 (10 mmol/L) at 37°C for 60 min. The reaction mixture was subsequently fractionated in sodium molybdate/isopropyl acetate. A sample of the organic phase was counted by scintillation. In the case of RhoGEF activity determinations, the RhoGEF exchange assay biochem kit (Cytoskeleton) was used according to manufacturer's instructions.
Immunoblotting
Equal amounts of beads were subjected to 15% (v/v) sodium dodecylsulfate-polyacrilamide gel electrophoresis and transferred to polyvinylidene difluoride membranes (Immobilon-P; Millipore Corporation, Bedford, MA, USA). Blots were blocked in 5%-nonfat dry milk/TBST buffer (20 mmol Tris-HCl, 150 mmol/L NaCl, 0.1% Tween-20) and immunoblotted for Rac1, Cdc42 and RhoA. Cdc42 and Rac1 were detected using either mouse anti-Cdc42 or anti-Rac1 primary antibodies (1 : 1000) with an overnight incubation at 4°C. RhoA was detected by using mouse anti-RhoA monoclonal primary antibody (1 : 500) with an overnight incubation at 4°C. a-tubulin was used as a loading control. Blots were then labelled with anti-mouse IgG HRP or anti-rabbit IgG HRP at 20°C and incubated with enhanced chemiluminescence detection reagent (Amersham Pharmacia Biotech, Piscataway, NJ, USA) according to the supplier's instructions. Bands were visualized by exposure of the membrane to Hyperfilm (Amersham Pharmacia Biotech). Quantification was performed by densitometric scanning of the film using a GS-700 Imaging Densitometer with Multi-Analyst 1.1 software (Bio-Rad Laboratories, Hercules, CA, USA). Endogenous total GTPase levels in lysates used for affinity purification were normalized to endogenous a-tubulin levels.
Phosphoinositide content
Astrocytes were cultured in the low-inositol containing medium 199 and labelled for 3 days with 1 lCi/mL myo-[2-3 H-Inositol] to approach isotopic equilibrium. After removing the medium, cells were washed twice in PBS and lipids were extracted with chloroform/methanol/concentrated HCl (100 : 200 : 1). Chloroformic lipid extracts (Bligh and Dyer 1959) were evaporated in a speed-vac concentrator. After addition of 20 lg mixed phosphoinositides (Sigma) as carrier, samples were spotted on silica gel 60 TLC plates (Merck), which were developed using methanol/ chloroform/NH 4 OH/water (48 : 40 : 5 : 10). Lipid bands were visualized with iodine vapor or with primuline spray. Silica gel areas corresponding to phosphatidylinositol (PI), phosphatidylinositol 4-phosphate (PIP) and PIP 2 (Rf values were 0.63, 0.47 and 0.25, respectively), which were identified by co-migration with carrier alone, were scraped into vials and counted for radioactivity.
Statistical analysis
Statistical analysis of results was performed using the one-way analysis of variance (ANOVA) followed by the Bonferroni's multiple comparison test (GraphPad Software, San Diego, CA, USA). Results were expressed as mean ± standard deviation (SD).
Results
Ethanol decreases activated RhoA and phosphoinositide levels in astrocytes Astrocytes were grown in the absence or in the presence of ethanol (30 and 100 mmol/L for 7 days). Untreated astrocytes (control) showed numerous well-organized actin stress fibers (Fig. 1a , panels i and ii), whereas a significant proportion (50%) of cells treated with high ethanol concentration (100 mmol/L) showed a variety of altered actin cytoskeleton patterns (Fig. 1a , panels iii and v), which basically consisted in having either a lower density of actin stress fibers (Fig. 1a, panel iv) or the actin cytoskeleton rearranged in a circle beneath the plasma membrane (Fig. 1a , panel vi) (Guasch et al. 2003; Tomás et al. 2003) . These alterations were milder in cells treated with 30 mmol/L ethanol (data not shown).
Next, untreated and ethanol-treated astrocytes were subjected to pull-down assays using GST-rhoketin to co-precipitate endogenous GTP-RhoA or GST-p21 activated kinase for endogenous GTP-Rac1 and GTP-Cdc42. Chronic ethanol treatments (30 and 100 mmol/L) significantly reduced endogenous levels of active RhoA (GTP-bound RhoA) in astrocytes isolated from the cortex (Fig. 1b, left panel; quantitative analysis shown in Fig. 1c ). In contrast, ethanol had no effect on the levels of active Rac1 or Cdc42 (Fig. 1b) . We also examined whether the ethanol-induced changes in activated RhoA pool were a consequence of an alteration in RhoA protein levels. As shown in Figs 1(d) and (e), ethanol did not affect the endogenous protein content of any Rho GTPase. To assess whether these ethanol-induced alterations on RhoGTPases are also produced in other brain regions, we tested astrocytes isolated from the cerebellum, which is one of the major areas affected by ethanol (Eckardt et al. 1998; West and Blake 2005) . After ethanol exposure, cerebellar astrocytes also showed actin cytoskeleton alterations, which were similar to those observed in cortical astrocytes (data not shown). Notably, only ethanol at 100 mmol/L decreased the endogenous activated RhoA pool (Fig. 1b , right panel; quantitative analysis in Fig. 1c ), but like in the case of cortical astrocytes without altering protein expression levels (Fig. 1d) .
Rho GTPases cycle between an inactive GDP-bound and an active GTP-bound form, whose activity is controlled by a large family of guanine nucleotide exchange factors (GEFs) and GAPs, and a few guanine nucleotide dissociation inhibitors (Jaffe and Hall 2005) . Therefore, the ethanolinduced decrease of activated RhoA pool could be equally caused by an increase in RhoGAP or by a decrease in RhoGEF activity. As shown in Fig. 2 , RhoGAP activity measured in ethanol-treated cell lysates was two fold greater than steadystate levels. RhoGEF activity was also measured but no significant differences were observed between untreated and ethanol-treated astrocytes (not shown). In sum, ethanol stimulates RhoGAP activity, which consequently results in the observed decrease in GTP-bound RhoA levels.
On the other hand, we have also previously postulated that ethanol-induced actin cytoskeleton alterations in astrocytes could be attributable to a decrease in PIP 2 levels (Tomás et al. 2003) , as this phosphoinositide is directly involved in the regulation of actin cytoskeleton (Yin and Janmey 2003; Logan and Mandato 2006) . To test this hypothesis, we examined the effects of ethanol (30 and 100 mmol/L) on PI, PIP and PIP 2 levels in rat cortex astrocytes. As shown in Fig. 3 , all three phosphoinositides significantly decreased in ethanol-treated cells, but being more robust for PIP 2 .
Lysophosphatidic acid normalizes activated RhoA and phosphoinositides pools decreased by ethanol We previously reported that LPA prevents ethanol-induced actin cytoskeleton alterations in ethanol-exposed astrocytes ( Fig. 4d) (Tomás et al. 2003) . As LPA activates Rhodependent signalling (Ridley and Hall 1992; Kranenburg et al. 1999; Ren et al. 1999 ) and ethanol decreases endogenous RhoA activation (Fig. 1) , we then examined whether LPA restored the endogenous levels of activated RhoA in ethanol-treated astrocytes. To this end, cortical and cerebellar astrocytes were treated with ethanol (100 mmol/L for 7 days) and LPA (1 lmol/L for 90 min at the end of the ethanol exposure). Cell lysates were subsequently subjected to pulldown experiments (Fig. 4a) . As previously indicated (Fig. 1b) , ethanol induced the decrease of activated RhoA, but not in cells that were submitted to LPA treatment (Figs 4a and b) . This was also confirmed using the colorimetric G-LISA assay, which measures endogenous Rho activation levels (Fig. 4c) . RhoA protein levels also remained unaltered (Fig. 4c, upper panel) .
Next, we examined whether the phosphoinositide pool decreased by ethanol (Fig. 5) is restored by LPA treatment. When LPA was added to ethanol-treated astrocytes as previously indicated, all three phosphoinositides examined recovered normal values (Fig. 5a ). No differences in total phosphoinositide labelling were observed in untreated and ethanol-treated cells (data not shown). To confirm the reversion induced by LPA on PIP 2 content in ethanol-treated astrocytes, PIP 2 levels were also measured using another experimental approach. Thus, cortical astrocytes were incubated with FBS and ethanol (100 mmol/L) for 5 days and then transferred to a low-serum medium containing [ 32 P] orthophosphate and ethanol for a further 3 days. Ethanol and LPA were added to the medium every 24 h. As shown in Fig. 5b , ethanol indeed diminished endogenous PIP 2 levels, but not in cells treated with LPA. Therefore, data show that ethanol reduces phosphoinositides levels in rat astrocytes and LPA is able to restore them to normal values.
Discussion
In the present study, in an attempt to examine the molecular mechanism by which ethanol alters actin cytoskeleton organization and dynamics, we examined the effects of moderate (30 mmol/L) and high (100 mmol/L) ethanol concentrations on the role of basic Rho GTPase family members (RhoA, Rac1 and Cdc42) as potential primary targets of ethanol. Notice that the ethanol concentrations used are comparable to blood alcohol concentrations observed in ethanol-tolerant individuals (up to 120 mmol/L) and pregnant women (up to 80 mmol/L) (Urso et al. 1981; Church and Gerkin 1988; Jones and Sternebring 1992; Eckardt et al. 1998) . Consequently, it is reasonable that fetuses of mothers who drink could be exposed to similar ethanol concentrations used in our study.
We have observed that ethanol diminishes the endogenous pool of active RhoA in primary cultures of rat astrocytes isolated from cortex and cerebellum, which are areas especially susceptible to ethanol effects during development (Eckardt et al. 1998; Cudd 2005) . In contrast, neither Rac1 nor Cdc42 was impaired by ethanol, which validates our hypothesis that RhoA is the major small Rho GTPase directly targeted by ethanol in rat astrocytes (Tomás et al. 2003) . Other recent reports have shown that ethanol impairs Rho GTPase signalling in different cell types (Slater et al. 2003; Joshi et al. 2006; Schaffert et al. 2006) and that this impairment seems to be related to actin cytoskeleton reorganization (Offenhauser et al. 2006) . Importantly, our results indicate that the total content of RhoA remains unchanged, which suggests that the ethanol-induced decrease of active RhoA is because of a shifting in GTP/GDP-bound RhoA equilibrium rather than to a previously reported downregulation of RhoA protein levels (Guasch et al. 2003) . The Rho GTPase cycle is regulated by GEFs, which exchange GDP for GTP and consequently promote the GTP-bound active form of Rho-GTPase, and by GAPs, which stimulate GTP hydrolysis and return Rho proteins to an inactive GDPbound state (Jaffe and Hall 2005) . Here, we observe that the ethanol-induced decrease in the GTP-bound RhoA pool results from a high increase in the RhoGAP activity and not from a decrease in RhoGEF activity. In this regard, changes in RhoGAP18B activity have been recently associated with ethanol sensitivity in Drosophila (Rothenfluh et al. 2006) . We reported that LPA reverts actin cytoskeleton alterations in ethanol-treated astrocytes (Tomás et al. 2003 and Fig. 4d) and that NIH3T3cells constitutively expressing activated RhoA mutant are resistant to the ethanol-induced alterations in actin (Tomás et al. 2003) . LPA activates the RhoA signalling pathway (Kranenburg et al. 1999 ) and induces GST-PBD C o n t r o l E t h a n o l E t h a n o l + L P A C o n t r o l E t h a n o l E t h a n o l + RhoA-mediated stress-fiber formation (Ridley and Hall 1992; Ren et al. 1999 ). Here we have extended this observation by examining the effect of LPA on the endogenous GTP-bound RhoA pool in cortical and cerebellar astrocytes exposed to ethanol, and indeed LPA normalizes endogenous GTP-RhoA levels in ethanol-exposed astrocytes.
RhoA is key player in the actin stress fibers formation (Ridley and Hall 1992) . Among the effectors of RhoA involved, the serine/threonine kinase ROCK regulates myosin light chain phosphorylation, which promotes the actin filament cross-linking activity of myosin II (Riento and Ridley 2003) . However, stress fiber formation in response to RhoA also involves other effectors such as phosphoinositides (Sahai et al. 1998; Yamamoto et al. 2001; Yoneda et al. 2005) . Here, we report that ethanol decreases the content of PI, PIP and PIP 2 . Phosphoinositides and their derivatives, despite their relatively low abundance, are essential regulators of actin dynamics and organization, which are fundamental in numerous cell processes such as membrane trafficking, cell motility and invasiveness (Yin and Janmey 2003; Lindmo and Stenmark 2006) . Thus, PIP and PIP 2 regulate cytoskeletal rearrangement through their association with a variety of actin-binding proteins (Lassing and Lindberg 1985; Yonezawa et al. 1990; Yin and Janmey 2003) . Increased formation of PIP 2 by over-expression of phosphatidylinositol-4-phosphate-5-kinase (PIP5K) also results in actin cytoskeleton reorganization (Shibasaki et al. 1997) , whereas exposure to PIP 2 phosphatase or microinjection of PIP 2 antibodies resulted in actin cytoskeleton disruption, decreased cell adhesion and the consequent cell rounding (Gilmore and Burridge 1996; Sakisaka et al. 1997; Raucher et al. 2000) . Thus, the decrease of phosphoinositides caused by ethanol could also explain the variety of actin cytoskeleton rearrangements seen in ethanol-treated astrocytes, which in addition may also be induced and even exacerbated by the fall in GTP-bound RhoA levels (Fig. 6 ). Ethanol could also decrease phosphoinositides content by its inhibitory action on phospholipase D (PLD) leading to a reduction of phosphatidic acid (Klein 2005) , whose decrease could in turn diminish the synthesis of PI catalysed by CDP-diacylglycerol synthase and PI synthase (Heacock and Agranoff 1997; Lykidis et al. 1997) (Fig. 6) . As the sequential phosphorylation of PI through phosphatidylinositol 4-kinase and PIP5K is a major route of PIP and PIP 2 generation, the induced decrease in PI levels should finally lead to lower levels of PIP and PIP 2 , which is what we observe in ethanol-treated astrocytes. At the same time, phosphatidic acid is likewise a direct activator of PIP5K (Jones et al. 2000; Skippen et al. 2002) . On the other hand, RhoA is a binding activator of PLD activity (Exton 2002; Klein 2005) . Thus, the putative involvement of the RhoA/PLD functional interaction must be taken into account to explain the decrease in all three phosphoinositides in ethanol-treated astrocyte (Fig. 6) . The finding that LPA treatment restored their normal levels favors the hypothesis of the RhoA-dependent PLD stimulation. In fact, several studies have shown such effective stimulation in fibroblasts, prostate cancer cells and neutrophils (Tou and Gill 2005) . Finally, there is also strong interaction between phosphoinositide kinases and the RhoA-dependent pathway. Thus, RhoA stimulates PIP5K activity, which implies a direct RhoA-controlled synthesis of PIP 2 (Oude Weernink et al. 2000 Weernink et al. , 2004 .
How do we explain the cytoprotective effect of LPA in ethanol-exposed astrocytes? At the same time that LPA activates RhoA-Rho kinase pathway and, consequently, directly stimulates the actin stress fiber formation (Fig. 6) , it could also rescue normal PIP 2 levels by stimulating PIP5K through the restitution of the normal GTP-bound RhoA pool. Consequently, this RhoA-induced stimulation of PIP 2 would also produce net actin polymerization in ethanol-treated astrocytes. The re-establishment of activated RhoA and phosphoinositide contents by LPA reported here is consistent with this postulate.
In conclusion, we demonstrate that ethanol reduces endogenous activated RhoA (because of an increase in RhoGAP activity) and phosphoinositides levels in primary cultures of rat astrocytes. These results provide an explanation of the molecular mechanisms involved in the impairments caused by ethanol on the actin cytoskeleton organization. Notably, LPA treatment restored both active RhoA and phosphoinositides pools, which supports the hypothesis that it protects cells from the harmful effects of ethanol. 
